The rising prevalence in GLP-1 agonists for diabetes has led to a discussion about application forms : skin-applied devices versus pills . Traditionally , GLP-1 therapies were exclusively available in pill https://teganliux596597.gynoblog.com/39745403/glp-1-skin-applications-vs-tablets-is-right-for-the-patient